IL122604A0 - Vinyl pyrrolidine cephalosporin derivatives their preparation and pharmaceutical compositions containing them - Google Patents

Vinyl pyrrolidine cephalosporin derivatives their preparation and pharmaceutical compositions containing them

Info

Publication number
IL122604A0
IL122604A0 IL12260497A IL12260497A IL122604A0 IL 122604 A0 IL122604 A0 IL 122604A0 IL 12260497 A IL12260497 A IL 12260497A IL 12260497 A IL12260497 A IL 12260497A IL 122604 A0 IL122604 A0 IL 122604A0
Authority
IL
Israel
Prior art keywords
hydrogen
formula
hydroxy
ylmethyl
omega
Prior art date
Application number
IL12260497A
Other languages
English (en)
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of IL122604A0 publication Critical patent/IL122604A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/572Five-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Peptides Or Proteins (AREA)
IL12260497A 1996-12-19 1997-12-15 Vinyl pyrrolidine cephalosporin derivatives their preparation and pharmaceutical compositions containing them IL122604A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP96120472 1996-12-19
EP97119528 1997-11-07

Publications (1)

Publication Number Publication Date
IL122604A0 true IL122604A0 (en) 1998-08-16

Family

ID=26142379

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12260497A IL122604A0 (en) 1996-12-19 1997-12-15 Vinyl pyrrolidine cephalosporin derivatives their preparation and pharmaceutical compositions containing them

Country Status (20)

Country Link
US (1) US5981519A (cs)
EP (1) EP0849269B9 (cs)
JP (2) JP3264877B2 (cs)
KR (3) KR100395985B1 (cs)
CN (5) CN1163496C (cs)
AT (1) ATE220402T1 (cs)
AU (1) AU729653B2 (cs)
CA (2) CA2628224C (cs)
CY (1) CY2400B1 (cs)
CZ (1) CZ405797A3 (cs)
DE (1) DE69713865T2 (cs)
DK (1) DK0849269T3 (cs)
ES (1) ES2179996T3 (cs)
HU (1) HUP9702474A3 (cs)
IL (1) IL122604A0 (cs)
MA (1) MA26457A1 (cs)
NO (1) NO975901L (cs)
NZ (1) NZ329363A (cs)
PT (1) PT849269E (cs)
TW (1) TW415949B (cs)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5977381A (en) * 1998-01-12 1999-11-02 Hoffmann-La Roche Inc. Process for making 3-amino-pyrolidine derivatives
US6232306B1 (en) * 1998-06-15 2001-05-15 Hoffmann-La Roche Inc. Derivatives of 3-(2-oxo-[1,3′]bipyrrolidinyl-3-ylidenemethyl)-cephams
ATE231871T1 (de) * 1998-06-15 2003-02-15 Basilea Pharmaceutica Ag 3-(2-oxo-(1,3')bipyrrolidinyl-3-yliden-methyl)- cephemderivate
AU1654900A (en) * 1998-12-03 2000-06-19 F. Hoffmann-La Roche Ag Bi-pyrrolidinylvinl (carba) cephalosporins
ATE370146T1 (de) 1999-07-05 2007-09-15 Basilea Pharmaceutica Ag Verfahren zur herstellung von cephalosporin- derivaten
WO2001004127A1 (en) * 1999-07-07 2001-01-18 F. Hoffmann-La Roche Ag Vinylpyrrolidinone derivatives with substituted thiazole ring
ATE341642T1 (de) 2000-04-19 2006-10-15 Basilea Pharmaceutica Ag Verfahren zur herstellung von d- asparaginderivaten
US6504025B2 (en) 2000-05-24 2003-01-07 Basilea Pharmaceutica Ag Process for the preparation of vinyl-pyrrolidinone cephalosporin derivatives
ES2251508T3 (es) * 2000-08-14 2006-05-01 Basilea Pharmaceutica Ag Preparacion de sales de fosfonio sustituidas por 3-pirrolidina lactama n-protegida.
ITMI20012363A1 (it) * 2001-11-09 2003-05-09 Antibioticos Spa Metodo per la sintesi di catene laterali di cefalosporine
EP1606293B1 (en) 2003-03-27 2009-08-19 Basilea Pharmaceutica AG Cephalosporin in crystalline form
EP2308562B1 (en) * 2003-12-25 2015-02-25 Ono Pharmaceutical Co., Ltd. Azetidine ring compounds and drugs comprising the same
US7569691B2 (en) * 2005-04-20 2009-08-04 Shin-Etsu Chemical Co., Ltd. Protected piperazino group-bearing organoxysilane compound and making method
CN101245081B (zh) * 2007-02-14 2010-10-13 山东轩竹医药科技有限公司 头孢菌素衍生物
CN101245079B (zh) * 2007-02-14 2010-07-07 山东轩竹医药科技有限公司 头孢抗生素衍生物
WO2009055696A1 (en) 2007-10-25 2009-04-30 Achaogen, Inc. CARBACEPHEM β-LACTAM ANTIBIOTICS
AR071318A1 (es) 2008-04-15 2010-06-09 Basilea Pharmaceutica Ag Benzhidril ester del acido (6r,7r)-7-{2-(5-amino-[1,2,4]tiadiazol-3-il)-2-[(z)-tritiloxiimino]-acetilamino}-3-[(r)-1'-terc-butoxicarbonil-2-oxo-[1,3']bipirrolidinil-(3e)-ilidenometil]-8-oxo-5-tia-1-aza-biciclo[4.2.0]oct-2-eno-2-carboxilico cristalino; su elaboracion y uso
WO2010030810A1 (en) * 2008-09-10 2010-03-18 Achaogen, Inc. Carbacephem beta-lactam antibiotics
WO2010072672A1 (en) 2008-12-24 2010-07-01 Basilea Pharmaceutica Ag New crystal polymorphs of ceftobiprole
CN101899059B (zh) * 2009-01-21 2012-02-15 山东轩竹医药科技有限公司 含有吡咯烷并环的头孢菌素衍生物
WO2010136423A1 (de) * 2009-05-25 2010-12-02 Sandoz Ag Verfahren zur herstellung von ceftobiprol medocaril
CN102030766B (zh) * 2009-09-30 2012-08-08 山东轩竹医药科技有限公司 含有二氢吡咯并杂环的头孢抗生素
CN103864851B (zh) * 2014-03-25 2016-08-17 华润赛科药业有限责任公司 作为前药的头孢吡普衍生物及其制备方法和用途
WO2024079094A1 (en) 2022-10-10 2024-04-18 Basilea Pharmaceutica International Ag, Allschwil Methods of treating staphylococcus aureus bacteremia infections

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL94946A0 (en) * 1989-07-13 1991-06-10 Eisai Co Ltd 3-substituted vinyl cephalosporin derivatives,their preparation and pharmaceutical compositions containing them
CA2147609A1 (en) * 1992-10-23 1994-05-11 Kohji Kawabata Cephem compounds, and their pharmaceutical compositions
US5523400A (en) * 1993-04-16 1996-06-04 Hoffmann-La Roche Inc. Cephalosporin antibiotics
DE69431691T2 (de) * 1993-04-16 2003-08-21 Basilea Pharmaceutica Ag Binni Cephalosporin-Derivate
DE69427365T2 (de) * 1993-09-29 2002-02-28 Meiji Seika Kaisha Ltd., Tokio/Tokyo Neue cephalosporinderivate
JPH08319291A (ja) * 1995-05-25 1996-12-03 Meiji Seika Kaisha Ltd 新規セフェム誘導体
AT403161B (de) * 1995-07-19 1997-11-25 Biochemie Gmbh Verfahren zur herstellung von cephemverbindungen

Also Published As

Publication number Publication date
DE69713865T2 (de) 2003-02-20
AU729653B2 (en) 2001-02-08
NO975901L (no) 1998-06-22
CN1104436C (zh) 2003-04-02
CN1163496C (zh) 2004-08-25
CZ405797A3 (cs) 1998-07-15
NZ329363A (en) 1999-01-28
KR100310384B1 (ko) 2001-11-08
AU4846397A (en) 1998-06-25
CN1325850A (zh) 2001-12-12
JPH10182657A (ja) 1998-07-07
EP0849269B9 (en) 2003-03-05
KR100331212B1 (ko) 2002-04-03
ATE220402T1 (de) 2002-07-15
DE69713865D1 (de) 2002-08-14
CY2400B1 (en) 2004-09-10
HUP9702474A3 (en) 2001-04-28
CN1347883A (zh) 2002-05-08
KR100395985B1 (ko) 2004-02-14
CN1198833C (zh) 2005-04-27
KR19980064240A (ko) 1998-10-07
CA2628224A1 (en) 1998-06-19
CN1347882A (zh) 2002-05-08
HUP9702474A2 (hu) 1998-11-30
JP4043203B2 (ja) 2008-02-06
CA2224438A1 (en) 1998-06-19
US5981519A (en) 1999-11-09
CN1183141C (zh) 2005-01-05
MA26457A1 (fr) 2004-12-20
NO975901D0 (no) 1997-12-16
DK0849269T3 (da) 2002-10-28
JP3264877B2 (ja) 2002-03-11
EP0849269B1 (en) 2002-07-10
CN1188112A (zh) 1998-07-22
CN1347884A (zh) 2002-05-08
TW415949B (en) 2000-12-21
PT849269E (pt) 2002-11-29
CA2628224C (en) 2010-02-16
CA2224438C (en) 2009-02-24
JP2002060390A (ja) 2002-02-26
EP0849269A1 (en) 1998-06-24
HU9702474D0 (en) 1998-03-02
CN1132833C (zh) 2003-12-31
ES2179996T3 (es) 2003-02-01

Similar Documents

Publication Publication Date Title
IL122604A0 (en) Vinyl pyrrolidine cephalosporin derivatives their preparation and pharmaceutical compositions containing them
DE68917023D1 (de) 3-Pyrrolidinylthio-1-azabicyclo[3.2.0]-hept-2-en-2-carbonsäureverbindungen.
AU663200B2 (en) New 3-(hydroxybenzylidenyl)-indolin-2-ones, processes for their preparation and pharmaceutical compositions containing them
GR3018212T3 (en) Naphtylalkylamines, process for their preparation and pharmaceutical compositions containing them.
HUT56370A (en) Process for producing tricyclic carbapenem derivatives and pharmaceutical compositions comprising such compounds as active ingredient
AU626740B2 (en) Aminocarbonylcarbamates related to physostigmine, a process for their preparation and their use as medicaments
AU636351B2 (en) N-heteroaryl-purin-6-amines, a process for their preparation and their use as medicaments
AU7581394A (en) Galanthamine derivatives, a process for their preparation and their use as medicaments
AU6487094A (en) 5-amino-8-methyl-7-pyrrolidinylquinoline-3-carboxylic acid derivative
CA2064108A1 (en) Thiazolidinone and Oxazolidinone Derivatives, Their Preparation and Their Use as Vasodilators
DE69429753D1 (de) Anitbiotisch wirksame Cephalosporine und Verfahren zu ihrer Herstellung
NZ332687A (en) use of 1-methyl-carbapenem derivatives as anti-helicobacter pylori agents
IL150100A0 (en) Pharmaceutical compositions containing fused cyclic compounds
AU657423B2 (en) Novel piperidine derivatives and process for preparation thereof
YU48197A (sh) Vinil-pirolidinski cefalosporini sa baznim supstituentima, njihova proizvodnja, intermedijeri koji se u njoj koriste, farmaceutski preparati koji sadrže krajnje proizvode i primena krajnjih priozvoda za proizvodnju lekova
IL109227A0 (en) Leustroducsin h, pharmaceutical composition containing the same, and processes for the preparation thereof
ECSP972346A (es) Cefalosporinas de vinil - pirrolidinonas con sustituyentes basicos